Anti- and proinflammatory effects of 15-deoxy-Δ-prostaglandin J 2(15d-PGJ2) on human eosinophil functions

International Archives of Allergy and Immunology

Volumn 143, Issue SUPPL. 1, 2007, Pages 15-22

  Ueki, Shigeharu ^a,b   Kato, Hikari ^a   Kobayashi, Yoshiki ^a   Ito, Wataru ^a   Adachi, Tetsuya ^b   Nagase, Hiroyuki ^b   Ohta, Ken ^b   Kayaba, Hiroyuki ^a   Chihara, Junichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

15 Deoxy delta12,14 prostaglandin J2; Allergy; Asthma; Chemoattractant receptor homologous molecule expressed on Th2 cells; Eosinophils; Peroxisome proliferator activated receptor gamma

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; EOTAXIN; MEMBRANE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ANTIINFLAMMATORY ACTIVITY; AUTOCRINE EFFECT; CELL FUNCTION; CHEMOTAXIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD11B; APOPTOSIS; AUTOCRINE COMMUNICATION; CALCIUM SIGNALING; CELL SHAPE; CHEMOTAXIS; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; HUMANS; INFLAMMATION; PARACRINE COMMUNICATION; PPAR GAMMA; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 34249808211     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101399     Document Type: Conference Paper

References (58)

1. 2 into human airways during acute antigen challenge. N Engl J Med 1986;315:800-804.
2. 2 in BAL fluid after methacholine challenge in asthmatic subjects. Eur Respir J 1993;6:405-412.
3. 2 in normal and asthmatic men. N Engl J Med 1984;311:209-213.
4. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y: Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002;168:443-449.
5. Lawrence T, Willoughby DA, Gilroy DW: Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002;2:787-795.
6. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT: Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 1991;146:2712-2718.
7. 4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996;118:1727-1735.
8. 2 and histamine activate human eosinophils. J Immunol 1992;148:3536-3542.
9. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001;98: 1942-1948.
10. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-261.
11. 2 and IL-5 reduce CRTH2 surface expression on human eosinophil. Allergol Int 2004;53:179-184.
12. Elsner J, Dulkys Y, Gupta S, Escher SE, Forssmann WG, Kapp A, Forssmann U: Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3. Allergy 2005; 60:1386-1393.
13. 2 receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003;69:169-177.
14. 2 receptor, CRTH2. Br J Pharmacol 2002;137:1163-1172.
15. 2 are potent activators of human eosinophils. J Immunol 2002;168:3563-3569.
16. 2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001;108:982-988.
17. 2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003;170:4752-4758.
18. 2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J Pharmacol Exp Ther 2005;313:64-69.
19. Kanegasaki S, Nomura Y, Nitta N, Akiyama S, Tamatani T, Goshoh Y, Yoshida T, Sato T, Kikuchi Y: A novel optical assay system for the quantitative measurement of chemotaxis. J Immunol Methods 2003;282:1-11.
20. 2- and indomethacin-induced agonist responses. Eur J Pharmacol 2005;524:30-37.
21. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995;83:813-819.
22. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995;83: 803-812.
23. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347:645-650.
24. Greene ME, Pitts J, McCarville MA, Wang XS, Newport JA, Edelstein C, Lee F, Ghosh S, Chu S: PPARγ: observations in the hematopoietic system. Prostaglandins Other Lipid Mediat 2000;62:45-73.
25. Ueki S, Adachi T, Bourdeaux Jessy, Oyamada H, Yamada Y, Hamada K, Kanda A, Kayaba H, Chihara J: Expression of PPARγ in eosinophis and its functional role in survival and chemotaxis. Immunol Lett 2003:86:183-189.
26. Ueki S, Usami A, Oyamada H, Saito N, Chiba T, Mahemuti G, Ito W, Kato H, Kayaba H, Chihara J: Procaterol upregulates peroxisome proliferator-activated receptor-γ expression in human eosinophils. Int Arch Allergy Immunol 2006;140(suppl 1):35-41.
27. 2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-γ ligation. J Immunol 2005;175: 5744-5750.
28. Shibuya A, Wada K, Nakajima A, Saeki M, Katayama K, Mayumi T, Kadowaki T, Niwa H, Kamisaki Y: Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett 2002;525:43-47.
29. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P, Megret J, Leseche G, Aubier M, Pretolani M: Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001;164:1487-1494.
30. Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA: Expression and function of PPARγ in rat and human vascular smooth muscle cells. Circulation 2000;101:1311-1318.
31. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD: A novel therapy for colitis utilizing PPAR-ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999;104:383-389.
32. Woerly G, Honda K, Loyens M, Papin J, Auwerx J, Staels B, Capron M, Dombrowicz D: Peroxisome proliferator-activated receptor α and γ down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003;198:411-421.
33. Usami A, Ueki S, Ito W, Kobayashi Y, Chiba T, Mahemuti G, Oyamada H, Kamada Y, Fujita M, Kato H, Saito N, Kayaba H, Chihara J: Theophylline and dexamethasone induce peroxisome proliferator-activated receptor-γ expression in human eosinophils. Pharmacology 2006;77:33-37.
34. Daynes RA, Jones DC: Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002;2:748-759.
35. Matsuwaki Y, Ueki S, Adachi T, Oyamada H, Kamada Y, Yamaguchi K, Kanda A, Hamada K, Kayaba H, Chihara J: The synthetic PPARγ agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils. Pharmacology 2005;74:169-173.
36. Mueller C, Weaver V, Vanden Heuvel JP, August A, Cantorna MT: Peroxisome proliferator-activated receptor γ ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys 2003;418:186-196.
37. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P: PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br J Pharmacol 2003;139:163-171.
38. Lee KS, Park SJ, Hwang PH, Yi HK, Song CH, Chai OH, Kim JS, Lee MK, Lee YC: PPAR-γ modulates allergic inflammation through up-regulation of PTEN. FASEB J 2005;19: 1033-1035.
39. Ueki S, Matsuwaki Y, Kayaba H, Oyamada H, Kanda A, Usami A, Saito N, Chihara J: Peroxisome proliferator-activated receptor γ regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 2004; 134(suppl 1):30-36.
40. 2: endogenous PPARγ ligand or minor eicosanoid degradation product? J Clin Invest 2003;112: 828-830.
41. 2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of IκB α degradation using a peroxisome proliferator-activated receptor-γ- independent mechanism. J Immunol 2002; 168:6232-6243.
42. 2: the anti-inflammatory prostaglandin? Clin Immunol 2005;114:100-109.
43. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998;273:25573-25580.
44. 2 in the rat brain. J Neurosci 2004; 24:1312-1318.
45. 2 and the ligation of PPARγ. J Clin Invest 2003;112: 945-955.
46. 2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem 2001;276:18950-18955.
47. 2 in nuclei. J Pharmacol Exp Ther 1987;242:306-311.
48. 2 to the PPARγ ligand-binding domain by multi-wavelength global fitting. Biochem J. 2006;393:749-755.
49. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982;129:1627-1631.
50. 2 by human helper T cell subsets. J Immunol 2000;164:2277-2280.
51. Sousa A, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, Lee TH: Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997;52:940-945.
52. 2 compounds by human eosinophils: a potential mast cell-eosinophil interaction. J Immunol 1988;141:2413-2419.
53. Kroegel C, Matthys H: Platelet-activating factor-induced human eosinophil activation: generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. Immunology 1993;78:279-285.
54. 2 into brain. Brain Res 1986;385:321-328.
55. 2 receptor. Biochem Biophys Res Commun. 2003;307:797-802.
56. 2 metabolite generated during inflammatory processes. J Biol Chem 2002;277:10459-10466.
57. 2 synthase enzymes and PPARγ are co-expressed in mouse 3T3-L1 adipocytes and human tissues. Prostaglandins Other Lipid Mediat 2003;70:267-284.
58. Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF: Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 2002;196:841-850.